Curaleaf Holdings, Inc. increased the target 2027 short-term incentive opportunity for Chairman and Chief Executive Officer Boris Jordan from 125 percent to 200 percent of his base salary, according to a Form 8-K filed with the U.S. Securities and Exchange Commission. The Compensation Committee and the Board of Directors approved the changes on September 28, 2026, to support the company's performance and strategic objectives.
The compensation package includes a discretionary target bonus of $1 million for the achievement of certain strategic targets. The Committee and the Board will evaluate these targets, with the final award amount to be determined in March 2028. Additionally, the board approved a one-time grant of 1,344,275 time-based restricted stock units to Mr. Jordan.
The grant has a fair value of $15,448,435 as of the grant date. These restricted stock units will vest in full on January 5, 2028. The award was issued under Curaleaf's 2018 Stock and Incentive Plan.
| Compensation Component | Details |
|---|---|
| 2027 Short-Term Incentive Target | Increased from 125% to 200% of base salary |
| Discretionary Target Bonus | $1 million for strategic targets |
| Restricted Stock Units | 1,344,275 units with a $15,448,435 grant date fair value |
| Vesting Date | January 5, 2028 |
Curaleaf Holdings, Inc., incorporated in British Columbia, Canada, is headquartered at 250 Harbor Drive, Third Floor, in Stamford, Connecticut. The company is identified by Commission File Number 333-249081 and I.R.S. Employer Identification Number 98-1461045. The Form 8-K report was signed on October 2, 2026, by Peter Clateman, Chief Legal Officer.